Tuesday, June 19, 2018

NEELIMA GONUGUNTLA AMONG THE DALLAS BUSINESS JOURNAL 2018 WOMEN IN BUSINESS AWARDS HONOREES


The 30 honorees, including US India Chamber of Commerce President, Neelima Gonuguntla represent a variety of industries and roles

DALLAS(TIP): The Dallas Business Journal has announced the honorees for its 11th annual Women in Business Awards program.

These 30 individuals, including Indian American Neelima Gonuguntla represent a variety of industries and roles that are crucial to the Dallas-Fort Worth ecosystem, including financial and legal services, commercial real estate and construction, and non-profit organizations.

From leaders of global institutions, like Frito-Lay Chief Marketing Officer Jennifer Saenz and AT&T Business’ Anne Chow, to entrepreneurs behind innovative startups, like Elyse Dickerson of Eosera, the 2018 class of Women in Business touches on a concentration of transformative ingenuity and enterprising imagination that can only be found in North Texas.

Four members of the Women in Business Awards class – Betty Garrett, Linda Kunz, Sandy Phillips, and Courtney Sinelli – have been selected to receive the distinction as a “Tourism, Travel and Hospitality” honoree. This category highlights the vital role that these verticals play in keeping North Texas a contender in national and international spheres.

Sreelakshmi Kolli, Sr.Vice President Align Technology



Sreelakshmi Kolli, Align's Senior.Vice President, Information Technology was the winner of 2017 Bay Area CIO of the Year award in the Innovation and Transformation category. The CIO of the Year awards are presented by the Silicon Valley Business Journal and the San Francisco Business Times, which serves to recognize local leaders who deploy IT in innovative ways to make an impact on the business. During Ms. Kolli's tenure, Align's infrastructures and applications have grown to support over 56,000 customers in over one hundred countries and 6,800 employees across the globe, including management of approximately three million data files and 15 terabytes of data per day, enabling the Company to have started over 4.5 million patients in Invisalign treatment to date.

Sreelakshmi Kolli is Senior Vice President, Global Information Technology responsible for defining the technology strategy and development of global consumer, customer and enterprise applications and infrastructure including end user and cloud computing, voice and data networks and storage. Ms. Kolli also leads the global program management office that manages and executes the company’s commercial and enterprise roadmap that includes product portfolio and cross-functional business programs. In addition, she led the company’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company. She joined the company in June 2003 and held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure and was promoted to Vice President, Information Technology (IT) in December 2012. Prior to joining Align Technology, Ms. Kolli held technical lead positions with Sword CT Space and Accenture. She is a member of the Executive Advisory Board at Salesforce.com. Ms. Kolli earned an M.S. degree in Computer Applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California


Align Technology, Inc.(NASDAQ: ALGN), designs, manufactures, and markets the invisalign system, a method for treating the misalignment of teeth. The Company offers a system that corrects the misalignment using a series of clear and removable appliances that move teeth to a desired final position. Align Technology serves customers worldwide.

Monday, June 18, 2018

Rithvik Bollipalli Signs on to Play at Utah State University


Utah State University and head men's tennis coach of the Aggies James Wilson June 4 announced that the team has added star Indian player Rithvik Chowdary Bollipalli to the squad.

“Utah State University is amazing and the entire team and staff are very friendly, supportive and encouraging,” Bollipalli said in a statement. “I love nature and the location is beyond exception and it inspires me to start every new day with very positive energy. The university has all the amenities for a tennis player.”

Bollipalli was the No. 1-ranked junior in all of India during U-12, U-14 and U-16 competition and has an International Tennis Federation ranking of 238 and a Universal Tennis Ranking of 12.72, the university said in a news release.

Bollipalli, who was a member of the India delegation at the 2017 Junior Davis Cup, captured a pair of tournament titles earlier this year, winning both the singles and doubles crown at the ITF Seventh Nairobi International Junior Championships in January, and then the singles and doubles titles at the ITF East African U-18 Junior Circuit in February, the release noted.

Bollipalli is excited about the coaching he will receive at Utah State to better his tennis career.

 “The coaching staff is awesome and I am very confident that under their expert guidance I will improve my tennis and fitness for they are exceptionally good and know what it takes to make a player,” he said. “I have full confidence in them that they will help me realize my dream to become a pro. Each player on the team is great and I am looking forward to learning from them. This is going to be my home away from home for next four years.”

Wilson, meanwhile, is excited at the prospect of the new signing making contributions to bettering the men’s tennis program at the university.

“Rithvik is going to be a great asset to our program,” Wilson said. “His mindset and work ethic are in line with our culture, and his overall game has tremendous potential. I am really looking forward to working with him, mostly because of his positive demeanor. I would expect him to make an immediate impact in our singles and doubles lineups.”

Bollipalli will join the university and the tennis program in the fall.

Friday, June 15, 2018

Rajeev Nannapaneni: A Champion At Home And Abroad


The launch of its generic viral flu medicine in the US, and its oncology & hepatitis C portfolio products in India brought Natco much success last year

During the financial year 2016-17, Natco Pharma became the first player to launch the generic version of Oseltamivir, a viral flu medicine, in the US market, creating a milestone for the industry. In the same year, the company’s oncology and hepatitis C portfolio products gained further strength in the Indian market.

“We saw an accelerated growth during the financial year due to Hepatitis C product growth in India and blockbuster launch of generic Oseltamivir in the US,” said Rajeev Nannapaneni, vice-chairman and CEO of Natco Pharma in the annual report of 2016-17 fiscal. “In formulations, new product sales have shown very good momentum and have improved total sales revenue significantly,” he added.

Going ahead, the company is looking at expanding its footprint in India and making significant investment in R&D. “Our business is driven by the scientific expertise of our R&D team and it forms the pillar of our product development capabilities,” said Nannapaneni, who joined the company in 2000. Currently 6-8 per cent of the company’s turnover is invested towards R&D each year.
   
In FY16-17, Natco Pharma’s revenue stood at Rs 20,789 million, its profit after tax (after minority interest) at Rs 4,860 million and its net worth was Rs 16,493 million.

Today, Natco Pharma is a leading player in India’s oncology segment with 28 active brands. Its flagship brands include Geftinat, Erlonat, Veenat and Sorafenat. The company has also heralded a new beginning in the gastro-hepatology therapy segment. Last year, it forayed into a new therapy segment by launching a Cardiology and Diabetology division.

“We are foraying into this segment with a clear objective to align it with our brand promise of offering well-focused niche products to consumers. We at Natco are encouraged by the growth opportunities the segment has to offer for specialised molecules,” said Nannapaneni. The product launches in the Hepatitis C basket have in fact helped the company gain a leading share of the market in India. The company’s consolidated revenue in FY16- 17 from Hepatitis C products grew to Rs 5,130 million, as opposed to Rs 3,412 million in FY15-16.

Globally, its products reach over 40 countries including North America, Latin America, Asia Pacific, South East Asia and Middle East.

As the US business landscape is facing challenges in the form of higher regulatory requirements, unfavourable pricing environment, intense competition and threat of new entrants, the company is looking to drive its long-term sustainability by enhancing its business opportunities in India and emerging markets. This is a part of its de-risking strategy.

Natco’s journey to enter the US and other key global markets started only about a decade ago. “We are cognisant of the immense growth opportunity that the domestic market can offer us to build a stronger financial profile,” said Nannapaneni adding that the company is looking to build its domestic capacities over the next few months.

With India’s economic prosperity improving, drug affordability and penetration of healthcare products and facilities will witness a boom. According to IMS Health and AIOCD AWACS, the industry’s revenue is expected to grow by 10-12 per cent CAGR over the next few years.

Natco Pharma was incorporated in Hyderabad in 1981 with an initial investment of Rs 3.3 million. The company today has seven manufacturing facilities spread across the country.

Thursday, June 14, 2018

Dhivya Suryadevara, First woman to become CFO of US biggest auto company GM


It's yet another proud moment for India and it doubles in scale as Dhivya Suryadevara has become the first woman Chief Financial Officer of the biggest auto company, General Motors.

Known as a financial wizard, Dhivya Suryadevara will succeed Chuck Stevens on September 1. Dhivya Suryadevara will be following the footsteps of Mary Barra who broke the glass ceiling when she became the first Chief Executive of the company.

Born and brought up in India, She earned bachelor’s and master’s degrees in commerce from the University of Madras in Chennai. Then, Dhivya Suryadevara moved to the United States for her higher studies at Harvard at the age of 22. She earned an MBA degree from there. She landed her first job at the investment bank UBS and joined General Motors, a year later, at an age of 25. Then there was no looking back. She was named Automotive News Rising Star in 2016 and a Crain’s Detroit Business 40 Under 40 winner last year.

“Dhivya’s experience and leadership in several key roles throughout our financial operations position her well to build on the strong business results we’ve delivered over the last several years,” Mary Barra, GM’s chief executive officer, said in a statement.

Just 39-years old, Dhivya Suryadevara played a role in securing a $2.25 billion investment in GM Cruise by Japanese tech giant SoftBank Group Corp earlier this month. She has played an integral role in some significant deals GM has made as it has restructured operations over the past several years, including the divestiture of the company’s European arm Opel and the acquisition of self-driving vehicle startup Cruise, Reuters reported.

With Suryadevara replacing Stevens, the Detroit-based automaker’s ranks will get closer to mirroring the share of women in senior jobs among S&P 500 companies, which is 27 percent, according to Catalyst, a nonprofit that tracks women in leaderships positions, Bloomberg reported.